Table 2.

Overall and Progression Free Survival (All patients)

Cohort A (No Metformin)	Cohort B (Metformin)
Overall Survival
• 67.7% patients alive at 1 year	• 88.2% patients alive at 1 year
• 62.0% patients alive at 2 years	• 73.3% patients alive at 2 years
• 20.7% patients alive at 3 years	• 73.3% patients alive at 3 years
Progression Free Survival
• 36.6% patients free from progression at 1 year	• 56.1% patients free from progression at 1 year
• 31.3% patients free from progression at 2 years	• 49.1% patients free from progression at 2 years